Aoki, Masahiko
Kadowaki, Shigenori
Takahashi, Naoki
Suzuki, Takeshi
Oshima, Kotoe
Ando, Takayuki
Yamamoto, Yoshiyuki
Kawakami, Kentaro
Kito, Yosuke
Matsumoto, Toshihiko
Shimozaki, Keitaro
Miyazaki, Yasuhiro
Yamaguchi, Toshifumi
Nagase, Michitaka
Tamura, Takao
Amanuma, Yusuke
Esaki, Taito
Miura, Yuji
Akiyoshi, Kohei
Baba, Eishi
Makiyama, Akitaka
Negoro, Yuji
Nakashima, Koji
Sugimoto, Naotoshi
Nagashima, Kengo
Shoji, Hirokazu
Boku, Narikazu http://orcid.org/0000-0002-1438-707X
Article History
Received: 1 September 2022
Accepted: 18 October 2022
First Online: 1 November 2022
Declarations
:
: Dr. Shigenori Kadowaki received research grants from Taiho, Lilly, MSD, Chugai, Nobelpharma, Ono, Daiichi Sankyo and Yansen, and honoraria from Lilly, Taiho, Ono, BMS, Chugai, Bayer, Merck Serono, Daiichi Sankyo and Eisai, outside the submitted work. Dr. Naoki Takahashi received honoraria from Taiho, Ono, and Bristol-Myers Squibb, outside the submitted work. Dr. Takayuki Ando received honoraria from Lilly, Taiho, Ono, Daiichi Sankyo and Bristol-Myers Squibb, outside the submitted work. Dr. Yoshiyuki Yamamoto received honoraria from Ono and Merck, outside the submitted work. Dr. Yosuke Kito received honoraria from Taiho, Takeda, Daiichi Sankyo and Merck BioPharma, outside the submitted work. Dr. Toshihiko Matsumoto received honoraria from Lilly, Taiho, Ono, Daiichi Sankyo, Merck and Bristol-Myers Squibb, outside the submitted work. Dr. Michitaka Nagase participated on a data safety monitoring board or advisory board of Chugai, outside the submitted work. Dr. Takao Tamura received research grants from Taiho and Chugai, and honoraria from Ono, Lilly, Takeda and Bristol-Myers Squibb, outside the submitted work. Dr. Taito Esaki received research grants from MSD, Novartis, Dainippon Sumitomo, Ono, Daiichi Sankyo, Astellas, Astellas Amgen Biopharma, Parexel, Chugai, Quintiles, Syneos Health and Pfyzer, and honoraria from MSD, Ono, Daiichi Sankyo, Lilly, Tahio, Chugai and Sanofi, outside the submitted work. Dr. Yuji Miura received honoraria from Astellas, Bristol-Myers Squibb, Eisai, Merck, MSD, Ono and Takeda, outside the submitted work. Dr. Eishi Baba received research grants from Taiho and Chugai, and honoraria from Ono, Chugai, Taiho, Lilly, Daiichi Sankyo, Merck, BMS, Novartis, Janssen, Miyarisan, MSD, Sanofi, Eisai and Takeda, and participated on a data safety monitoring board or advisory board of Daiichi Sankyo, Astellas and AstraZeneca, outside the submitted work. Dr. Akitaka Makiyama received honoraria from Lilly, Taiho, Ono, Daiichi Sankyo and Bristol-Myers Squibb, outside the submitted work. Dr. Kengo Nagashima received consulting fees from Fujimoto, SENJU and Toray Industries, outside the submitted work. Dr. Hirokazu Shoji received honoraria from Ono, and other financial or non-financial interests from Ono, MSD and Astellas, outside the submitted work. Dr. Narikazu Boku received research grants from Takeda and Ono, and honoraria from Taiho, Ono, Daiichi Sankyo and Bristol-Myers Squibb, outside the submitted work. All remaining authors have declared no conflicts of interest.